Biomarker

Study on serum proteomic features in patients with and without recurrence or metastasis after surgical resection of esophageal carcinoma

G. B. Zheng, Gao, C. F., Wang, X. L., Zhao, G., and Li, D. H., Study on serum proteomic features in patients with and without recurrence or metastasis after surgical resection of esophageal carcinoma, vol. 13, pp. 538-545, 2014.

The purpose of this study was to identify specific bio­markers for recurrence or metastasis of esophageal carcinoma in serum of patients subjected to esophagectomy. Surface-enhanced laser desorp­tion/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) combined with IMAC-Cu2+ ProteinChip array were performed for the serum protein profiling in patients after surgical resection of esophageal carcinoma. Two groups of patients were analyzed: 38 patients without recurrence or metastasis (Group 1) and 22 patients with recurrence or metastasis after resection (Group 2).

Analysis of protein-protein interaction network in chronic obstructive pulmonary disease

Y. P. Yuan, Shi, Y. H., and Gu, W. C., Analysis of protein-protein interaction network in chronic obstructive pulmonary disease, vol. 13, pp. 8862-8869, 2014.

Chronic obstructive pulmonary disease (COPD) is a growing cause of morbidity and mortality throughout the world. The purpose of our study was to uncover biomarkers and explore its pathogenic mechanisms at the molecular level. The gene expression profiles of COPD samples and normal controls were downloaded from Gene Expression Omnibus. Matlab was used for data preprocessing and SAM4.0 was applied to determine the differentially expressed genes (DEGs).

Advanced oxidation protein products as a biomarker of cutaneous lupus erythematosus complicated by nephritis: a case-control study

Z. Xie, Zhang, M., Zhao, B., Wang, Q., Li, J., Liu, Y. Y., and Chen, Y. H., Advanced oxidation protein products as a biomarker of cutaneous lupus erythematosus complicated by nephritis: a case-control study, vol. 13, pp. 9213-9219, 2014.

Oxidative stress is involved in the pathogenesis of lupus nephritis (LN). The current study investigated the significance of advanced oxidation protein products (AOPPs) as a biomarker of LN in patients with cutaneous lupus erythematosus. Ninety-two patients who initially presented with systemic lupus erythematosus were divided into the LN- and LN+ groups. Serum AOPP levels were determined, and the association between AOPP levels and LN was investigated in a case-control study.

Circulatory microRNA-145 expression is increased in cerebral ischemia

C. S. Gan, Wang, C. W., and Tan, K. S., Circulatory microRNA-145 expression is increased in cerebral ischemia, vol. 11. pp. 147-152, 2012.

Cerebral ischemia or ischemic stroke is mainly attributed to vascular and circulation disorders. Among protein biomarkers, RNA profiles have also been identified as markers of ischemic stroke. MicroRNA-145 expression is ostensibly recognized as marker and modulator of vascular smooth muscle cell phenotype; however, expression levels in ischemic stroke had not been investigated. Employing real-time quantitative PCR, we examined the expression profile of circulatory microRNA-145 in healthy control subjects (N = 14) and ischemic stroke patients (N = 32).

Plasma human mammaglobin mRNA associated with poor outcome in patients with breast cancer

G. - W. Lee, Kim, J. - Y., Koh, E. - H., Kang, D., Choi, D. S., Maeng, K. - Y., and Lee, J. - S., Plasma human mammaglobin mRNA associated with poor outcome in patients with breast cancer, vol. 11, pp. 4034-4042, 2012.

Different treatment outcomes and prognoses in patients with breast cancer can be observed with similar clinical predictors; this is because the biology of breast cancer is complex and heterogenous, involving multiple unknown contributing factors. We looked for plasma human mammaglobin (hMAM) mRNA by RT-PCR in 82 Korean patients with breast cancer to determine if there is an association between the presence of plasma hMAM mRNA in these patients and known prognostic factors.

Association between survivin gene promoter -31G/C and -644C/T polymorphisms and non-small cell lung cancer

E. Aynaci, Coskunpinar, E., Eren, A., Kum, O., Oltulu, Y. M., Akkaya, N., Turna, A., Yaylim, I., and Yildiz, P., Association between survivin gene promoter -31G/C and -644C/T polymorphisms and non-small cell lung cancer, vol. 12, pp. 3975-3982, 2013.

Lung cancer is the most common cancer worldwide. Survivin is one of the first reported inhibitors of apoptosis proteins, which is an important family of proteins that regulate apoptosis. The survivin gene is located on human chromosome 17q25, which is composed of 142 amino acids. A common polymorphism of the survivin gene promoter -31G/C has been shown to influence cancer risk. This genetic variant has been associated with overexpression of survivin at both protein and mRNA levels in cancer cells.

Parallel proteomic analysis in muscle-invasive bladder transitional cell carcinoma and cancer-related stroma

H. T. Niu, Qi, X. J., Liu, Y. Q., Cao, Y. W., Dong, Q., and Wang, X. S., Parallel proteomic analysis in muscle-invasive bladder transitional cell carcinoma and cancer-related stroma, vol. 12, pp. 4251-4263, 2013.

To bring about improvements in cancer biology research and elucidate mechanism-based therapeutic targets, we studied the proteome expression profile of purified normal urothelial cells (cancer cells) and normal stromal cells (cancerous stromal cells). Based on the expression profile, biomarker discovery and the mechanisms of multi-step carcinogenesis were explored. We found that 1412/1403 unique proteins commonly appeared in 4 sets of paired cancer/normal tissue, and 1753 proteins were differentially expressed.

A novel TET2 mutation in a patient with refractory cytopenia with multilineage dysplasia

D. F. Coutinho, Diniz, C., Filgueiras, R. L. D., Baptista, R. L. R., Ayres-Silva, J. P., Monte-Mór, B. C. R., Bonamino, M. H., and Zalcberg, I. R., A novel TET2 mutation in a patient with refractory cytopenia with multilineage dysplasia, vol. 12. pp. 5858-5862, 2013.

Myelodysplastic syndrome diagnosis of karyotypically normal patients may be elusive because it relies exclusively on morphological and clinical data. In routine practice, finding of an acquired mutation or a cytogenetic abnormality provides irrefutable evidence of the clonal nature of that disease. Recurrent deletions and somatic mutations in TET2, a gene involved in epigenetic regulation, have been reported in about 20% of adult patients with myelodysplastic syndrome.

Subscribe to Biomarker